Reaction Details Report a problem with these data
Target
Complement factor D
Ligand
BDBM468660
Substrate
n/a
Meas. Tech.
TBD
IC50
5500±n/a nM
Citation
Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W Compounds for treatment of immune inflammatory disorders US Patent US10807952 Publication Date 10/20/2020
More Info.:
Target
Name:
Complement factor D
Synonyms:
Adipsin | C3 convertase activator | CFAD_HUMAN | CFD | DF | PFD | Properdin factor D
Type:
Protein
Mol. Mass.:
27039.19
Organism:
Homo sapiens (Human)
Description:
P00746
Residue:
253
Sequence:
MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA
Inhibitor
Name:
BDBM468660
Synonyms:
US10807952, Cmp No. 64 | US11001600, Cmp No. 49 | tert-butyl ((3'- ((2S,4R)-1-(2-(3- carbamoyl-1H- indazol-1- yl)acetyl)-4- fluoropyrrolidine-2- carboxamido)-2'- fluoro-[1,1'- biphenyl]-3- yl)(methyl)(oxo)- $#9633;6-sulfanylidene)- $#9633;4- azanecarboxylate
Type:
Small organic molecule
Emp. Form.:
C33H34F2N6O6S
Mol. Mass.:
680.721
SMILES:
CC(C)(C)OC(=O)N=S(C)(=O)c1cccc(c1)-c1cccc(NC(=O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2nc(C(N)=O)c3ccccc23)c1F |r|